These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29057167)

  • 1. Pharmacogenetics in Cardiovascular Medicine.
    Tuteja S; Limdi N
    Curr Genet Med Rep; 2016 Sep; 4(3):119-129. PubMed ID: 29057167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine.
    Dávila-Fajardo CL; Díaz-Villamarín X; Antúnez-Rodríguez A; Fernández-Gómez AE; García-Navas P; Martínez-González LJ; Dávila-Fajardo JA; Barrera JC
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30939847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacogenetics implementation: approaches, successes, and challenges.
    Weitzel KW; Elsey AR; Langaee TY; Burkley B; Nessl DR; Obeng AO; Staley BJ; Dong HJ; Allan RW; Liu JF; Cooper-Dehoff RM; Anderson RD; Conlon M; Clare-Salzler MJ; Nelson DR; Johnson JA
    Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):56-67. PubMed ID: 24616371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics to guide cardiovascular drug therapy.
    Duarte JD; Cavallari LH
    Nat Rev Cardiol; 2021 Sep; 18(9):649-665. PubMed ID: 33953382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art.
    Ross S; Krebs K; Paré G; Milani L
    Stroke; 2023 Jan; 54(1):270-278. PubMed ID: 36325912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Pharmacogenetics for Precision Medicine: Successes and Setbacks.
    Chambliss AB; Marzinke MA
    J Appl Lab Med; 2018 Nov; 3(3):474-486. PubMed ID: 33636912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence.
    Gower MN; Ratner LR; Williams AK; Rossi JS; Stouffer GA; Lee CR
    Pharmgenomics Pers Med; 2020; 13():239-252. PubMed ID: 32821149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.
    Kaufman AL; Spitz J; Jacobs M; Sorrentino M; Yuen S; Danahey K; Saner D; Klein TE; Altman RB; Ratain MJ; O'Donnell PH
    Mayo Clin Proc; 2015 Jun; 90(6):716-29. PubMed ID: 26046407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of inpatient models of pharmacogenetics programs.
    Cavallari LH; Lee CR; Duarte JD; Nutescu EA; Weitzel KW; Stouffer GA; Johnson JA
    Am J Health Syst Pharm; 2016 Dec; 73(23):1944-1954. PubMed ID: 27864202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHARMACOGENOMIC DETERMINANTS OF RESPONSE TO CARDIOVASCULAR DRUGS.
    Stankov KM; Stanimirov BG; Mikov MM
    Med Pregl; 2015; 68(7-8):259-65. PubMed ID: 26591639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic determinants of response to cardiovascular drugs.
    Wells QS; Delaney JT; Roden DM
    Curr Opin Cardiol; 2012 May; 27(3):253-61. PubMed ID: 22382501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics in clinical pediatrics: challenges and strategies.
    Van Driest SL; McGregor TL
    Per Med; 2013 Sep; 10(7):. PubMed ID: 24363766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.
    Cavallari LH; Nutescu EA
    Clin Pharmacol Ther; 2014 Jul; 96(1):22-4. PubMed ID: 24942399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 genotype-guided drug therapies: An update on current states.
    Dong AN; Tan BH; Pan Y; Ong CE
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):991-1001. PubMed ID: 29858511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-guided warfarin therapy: current status.
    Tavares LC; Marcatto LR; Santos PCJL
    Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).
    Lamoureux F; Duflot T;
    Therapie; 2017 Apr; 72(2):257-267. PubMed ID: 28237404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Application of Pharmacogenetics: Where are We Now?
    van Schaik RH;
    EJIFCC; 2013 Feb; 24(3):105-12. PubMed ID: 27683445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
    Zaiou M; El Amri H
    Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics in Cardiovascular Medicine.
    Weeke PE
    Adv Pharmacol; 2018; 83():333-360. PubMed ID: 29801582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Evidence Standards Different for Genomic- vs. Clinical-Based Precision Medicine? A Quantitative Analysis of Individualized Warfarin Therapy.
    Dhanda DS; Guzauskas GF; Carlson JJ; Basu A; Veenstra DL
    Clin Pharmacol Ther; 2017 Nov; 102(5):805-814. PubMed ID: 28187492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.